Literature DB >> 25848534

Role of syndecan-2 in osteoblast biology and pathology.

Rafik Mansouri1, Eric Haÿ1, Pierre J Marie1, Dominique Modrowski1.   

Abstract

Syndecans 1-4 are a family of transmembrane proteins composed of a core protein and glycosaminoglycan chains. Although the four syndecans have common functions, they appear to be connected to different signaling pathways, and their expression occurs in a cell- and development-specific pattern. In contrast to other syndecans, syndecan-2 expression increases during osteoblast differentiation. Mechanistically, syndecan-2 exerts multiple functions in cells of the osteoblast lineage as it serves as a co-receptor for fibroblast growth factors and Wnt proteins and controls cell adhesion, proliferation, differentiation and apoptosis. Recent studies indicate that syndecan-2 also contributes to osteosarcoma cell response to cytotoxic agents through interactions with Wnt/β-catenin signaling. Here we summarize our current understanding of the role of syndecan-2 in the control of osteoblast biology and pathology and discuss how syndecan-2 acts as a modulator of the bone cell microenvironment.

Entities:  

Year:  2015        PMID: 25848534      PMCID: PMC4382859          DOI: 10.1038/bonekey.2015.33

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  50 in total

Review 1.  Structure and functions of syndecans in vertebrates.

Authors:  E I Leonova; O V Galzitskaya
Journal:  Biochemistry (Mosc)       Date:  2013-10       Impact factor: 2.487

2.  Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.

Authors:  Jaime Gutierrez; Nelson Osses; Enrique Brandan
Journal:  J Cell Physiol       Date:  2006-01       Impact factor: 6.384

3.  Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.

Authors:  Dominique Modrowski; Armelle Orosco; Judicaël Thévenard; Olivia Fromigué; Pierre J Marie
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

4.  Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.

Authors:  François-Xavier Dieudonné; Allison Marion; Pierre J Marie; Dominique Modrowski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

5.  Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.

Authors:  M A Birch; T M Skerry
Journal:  Bone       Date:  1999-06       Impact factor: 4.398

6.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

7.  Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.

Authors:  Heui-Young Ryu; Jiseon Lee; Sanghwa Yang; Haein Park; Sojoong Choi; Kyeong-Cheon Jung; Seung-Taek Lee; Je-Kyung Seong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.

Authors:  Nadiya M Teplyuk; Larisa M Haupt; Ling Ling; Christian Dombrowski; Foong Kin Mun; Saminathan S Nathan; Jane B Lian; Janet L Stein; Gary S Stein; Simon M Cool; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

9.  The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.

Authors:  Annouck Luyten; Eva Mortier; Claude Van Campenhout; Vincent Taelman; Gisèle Degeest; Gunther Wuytens; Kathleen Lambaerts; Guido David; Eric J Bellefroid; Pascale Zimmermann
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

10.  Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice.

Authors:  Jessica Bertrand; Richard Stange; Heriburg Hidding; Frank Echtermeyer; Giovanna Nalesso; Lars Godmann; Melanie Timmen; Peter Bruckner; Francesco Dell'Accio; Michael J Raschke; Thomas Pap; Rita Dreier
Journal:  Arthritis Rheum       Date:  2013-03
View more
  5 in total

Review 1.  Cardiac fibrosis and curcumin: a novel perspective on this natural medicine.

Authors:  Fatemeh Sadoughi; Jamal Hallajzadeh; Liaosadat Mirsafaei; Zatollah Asemi; Mahdi Zahedi; Mohammad Ali Mansournia; Bahman Yousefi
Journal:  Mol Biol Rep       Date:  2021-10-14       Impact factor: 2.316

2.  miR-218 affects the ECM composition and cell biomechanical properties of glioblastoma cells.

Authors:  Małgorzata Grabowska; Konrad Kuczyński; Monika Piwecka; Alicja Rabiasz; Joanna Zemła; Paweł Głodowicz; Dariusz Wawrzyniak; Małgorzata Lekka; Katarzyna Rolle
Journal:  J Cell Mol Med       Date:  2022-06-15       Impact factor: 5.295

3.  Methylation of SDC2/TFPI2 and Its Diagnostic Value in Colorectal Tumorous Lesions.

Authors:  Lianglu Zhang; Lanlan Dong; Changming Lu; Wenxian Huang; Cuiping Yang; Qian Wang; Qian Wang; Ruixue Lei; Rui Sun; Kangkang Wan; Tingting Li; Fan Sun; Tian Gan; Jun Lin; Lei Yin
Journal:  Front Mol Biosci       Date:  2021-12-22

4.  Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma.

Authors:  Zhiquan Hao; Siqiao Wang; Zixuan Zheng; Jiehan Li; Wanting Fu; Donglin Han; Yinrou Huang; Qing Lin; Shuyuan Xian; Penghui Yan; Man Li; Ruoyi Lin; Tong Meng; Jie Zhang; Zongqiang Huang
Journal:  Biomed Res Int       Date:  2022-01-27       Impact factor: 3.411

5.  MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene.

Authors:  Fangfang Zhao; Youguang Pu; Mingda Cui; Haiyan Wang; Shanbao Cai
Journal:  Cancer Cell Int       Date:  2017-11-02       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.